Clinical Trial Update: Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on pediatric cinacalcet for secondary hyperparathyroidism due to chronic kidney disease (Phase 2/3). The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: ENRICO VERRINA | Conditions: Secondary Hyperparathyroidism | Phase 2, Phase 3 | Status: UNKNOWN